The management of complex patients with inoperable stage III NSCLC: practical lessons from case-based discussion
Christoper Hooper, Matthew Anderson, Sarah Bowen Jones, Corinne Faivre-Finn et autres
BACKGROUND: Standard of care for inoperable and/or unresectable stage III non-small cell lung cancer (NSCLC) is concurrent chemoradiotherapy followed by 12 months of adjuvant durvalumab. Many patients are ineligible due to poor fitness, comorbidity or concerns around their ability to tolerate concurrent …
gb (code pays fourni par la source)